Drug recall · December 4, 2024
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH recall
Why: cGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031
- Lots / codes
a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6
- Quantity
- 455,536 patches
- Company
- Unexo Life Sciences Private Limited, New Delhi
- Distribution
- Nationwide in the US
- Initiated
- October 24, 2024 · Voluntary: Firm initiated
- Classified
- November 22, 2024
- Reported
- December 4, 2024
- Ended
- September 16, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.